TradingNote
Gurus
Top InvestorsCongress TradesInsider Trades

Top Investors

Warren BuffettCathie WoodLi LuRay DalioBill AckmanView all Top Investors
Archive
Industry
AI & ComputeSoftware & DigitalHealthcare InnovationFinancial InfrastructureEnergy & GridIndustrial AutomationConsumer & CommerceReal Estate & AssetsMaterials & ManufacturingListed Vehicles

AI & Compute

Semiconductors & AcceleratorsCloud & AI PlatformsData Center & NetworkingView all AI & Compute
ResearchApp

ICAD

iCAD, Inc.

Investor Moves

NameValueActionChangePriceCurrent Price
Ken GriffinCitadel Advisors
$-237.7K
ExitQ3 2025
$238k
--
$3.87
Jim SimonsRenaissance Technologies
$-1.3M
ExitQ3 2025
$1M
--
$3.87
First Eagle InvestmentsInvestor
$-2.2M
ExitQ3 2025
$2M
--
$3.87
Ken GriffinCitadel Advisors
$-330.0K
TrimQ2 2025
$330k
--
$3.87
Jim SimonsRenaissance Technologies
$-19.0K
TrimQ2 2025
$19k
--
$3.87
First Eagle InvestmentsInvestor
$713.3K
AddQ2 2025
$713k
--
$3.87
Trade ICAD

About iCAD, Inc.

iCAD, Inc. specializes in delivering advanced solutions for cancer management, encompassing sophisticated image analysis tools, streamlined workflow optimization, and targeted radiation therapy. While primarily operating in the United States, the company also maintains a significant international presence. Its operations are organized into two principal divisions: Cancer Detection and Cancer Therapy. In the Cancer Detection segment, iCAD provides a range of innovative technologies. This includes the PowerLook platform, which serves as a central host for artificial intelligence algorithms and facilitates seamless communication between imaging acquisition devices, storage systems, and review platforms. Key diagnostic offerings feature SecondLook, a machine learning-driven algorithm designed to examine 2D full-field digital mammography images for identifying and marking suspicious masses and calcifications. Additionally, the company offers automated solutions for consistent and standardized assessment of breast density. Its portfolio further extends to ProFound AI, a deep-learning algorithm adept at detecting malignant soft-tissue densities and calcifications within digital breast tomosynthesis, and ProFound AI Risk, a tool that provides breast cancer risk estimation derived from screening mammograms. Magnetic resonance imaging (MRI) applications are also available for detecting breast and prostate cancer, along with VeraLook, a solution supporting the identification of colonic polyps in conjunction with CT Colonography. The Cancer Therapy division features the Xoft Axxent electronic brachytherapy systems. These systems are employed in the treatment of early-stage breast, non-melanoma skin, and gynecological cancers. Their clientele is diverse, spanning university research centers, community hospitals, specialized cancer care clinics, veterinary facilities, and dermatology practices. iCAD distributes its products through multiple channels, utilizing its own direct sales organizations, as well as collaborating with original equipment manufacturer (OEM) partners, various distributors, technology platform partners, and resellers. The company also has a global footprint, exporting its advanced technologies to regions including Europe, Taiwan, Canada, China, and other international markets. Originally established in 1984 under the name Howtek, Inc., the company was rebranded as iCAD, Inc. in June 2002. Its corporate headquarters are located in Nashua, New Hampshire.

CEO
Dana R. Brown
IPO Date
Dec 13, 1984

Market Data

OpenThe first traded price for the current trading session.
$3.87
HighThe highest traded price in the current trading session.
$3.87
LowThe lowest traded price in the current trading session.
$3.87
VolumeTotal shares traded during the current trading session.
190.1K
Avg VolumeAverage number of shares traded per session, as reported by FMP.
789.1K
52W HighThe highest traded price over the past 52 weeks.
$4.01
52W LowThe lowest traded price over the past 52 weeks.
$1.19

Valuation

Market CapCompany equity value based on share price multiplied by shares outstanding.
$106.3M
Enterprise ValueMarket cap plus debt and other claims, less cash and equivalents.
$86.6M
Dividend YieldAnnualized dividend yield relative to the current share price.
0.00%

Financials

Free Cash FlowOperating cash flow minus capital expenditures from the latest annual cash flow statement.
-$4.1M
RevenueTotal sales from the latest annual income statement.
$19.6M
Net IncomeProfit after expenses and taxes from the latest annual income statement.
-$5.6M
CashCash and equivalents, or cash plus short-term investments, from the latest balance sheet.
$17.2M
DebtTotal debt from the latest balance sheet.
$362K

Events

EarningsAug 12

EPS est. -0.055 · actual -0.07

Top Market Industries

AI & Compute
  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking
Software & Digital
  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media
Healthcare
  • GLP-1 & Metabolic Health
  • Biotech & Oncology
  • Medical Devices & Diagnostics
  • Healthcare Services
  • Pharmaceuticals
Financial Infrastructure
  • Banks & Capital Markets
  • Asset Management & Exchanges
  • Insurance
  • Payments & Fintech
  • Digital Assets
Energy & Grid
  • Oil, Gas & Fuels
  • Nuclear & Grid Power
  • Renewables & Storage
  • Utilities
  • Energy Services
Industrial Automation & Defense
  • Aerospace & Defense
  • Robotics & Automation
  • Machinery & Equipment
  • Logistics & Transportation
  • Construction & Infrastructure
Consumer & Commerce
  • Retail & E-commerce
  • Restaurants & Food Service
  • Consumer Brands
  • Autos & Mobility
  • Travel & Leisure
Real Estate & Physical Assets
  • REITs
  • Real Estate Services
  • Housing & Building Products

AI & Compute

  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking

Software & Digital

  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media

Healthcare

  • GLP-1 & Metabolic Health
  • Biotech & Oncology
  • Medical Devices & Diagnostics
  • Healthcare Services
  • Pharmaceuticals

Financial Infrastructure

  • Banks & Capital Markets
  • Asset Management & Exchanges
  • Insurance
  • Payments & Fintech
  • Digital Assets

Energy & Grid

  • Oil, Gas & Fuels
  • Nuclear & Grid Power
  • Renewables & Storage
  • Utilities
  • Energy Services

Industrial Automation & Defense

  • Aerospace & Defense
  • Robotics & Automation
  • Machinery & Equipment
  • Logistics & Transportation
  • Construction & Infrastructure

Consumer & Commerce

  • Retail & E-commerce
  • Restaurants & Food Service
  • Consumer Brands
  • Autos & Mobility
  • Travel & Leisure

Real Estate & Physical Assets

  • REITs
  • Real Estate Services
  • Housing & Building Products
Trending Industries
  • AI & Compute Infrastructure
  • Software & Digital Platforms
  • Healthcare Innovation
  • Financial Infrastructure
  • Energy & Grid
  • Industrial Automation & Defense
  • Consumer & Commerce
  • Real Estate & Physical Assets
Top Investors
  • Warren Buffett
  • Cathie Wood
  • Li Lu
  • Ray Dalio
  • Bill Ackman
  • Duan Yongping
  • Michael Burry
  • Ken Griffin
Trending Stocks
  • NEE
  • NVDA
  • LLY
  • MSFT
  • AAPL
  • META
  • AMD
  • AMZN
Browse
  • App
  • Archive
  • Industries
  • Categories
  • Investors
  • Methodology
  • Watchlist

Trending Industries

  • AI & Compute Infrastructure
  • Software & Digital Platforms
  • Healthcare Innovation
  • Financial Infrastructure
  • Energy & Grid
  • Industrial Automation & Defense
  • Consumer & Commerce
  • Real Estate & Physical Assets

Top Investors

  • Warren Buffett
  • Cathie Wood
  • Li Lu
  • Ray Dalio
  • Bill Ackman
  • Duan Yongping
  • Michael Burry
  • Ken Griffin

Trending Stocks

  • NEE
  • NVDA
  • LLY
  • MSFT
  • AAPL
  • META
  • AMD
  • AMZN

Browse

  • App
  • Archive
  • Industries
  • Categories
  • Investors
  • Methodology
  • Watchlist
© 2026 TradingNote
AppArchiveIndustriesCategoriesInvestorsMethodologyWatchlistPrivacyTerms